XML 19 R8.htm IDEA: XBRL DOCUMENT v3.26.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating Activities:    
Net income $ 523,255 $ 482,305
Adjustments to reconcile net income to net cash from operating activities:    
Credit loss expense 28,602 32,978
Deferred tax expense (benefit) (7,124) 3,047
Accretion of loan discounts (24,079) (20,588)
Securities premium amortization (discount accretion), net 6,330 28,907
Net (gain) loss on securities transactions 7,512 14
Depreciation and amortization 67,479 65,969
Net (gain) loss on sale/write-down of assets/foreclosed assets (8,276) (2,294)
Stock-based compensation 16,206 13,183
Net tax benefit from stock-based compensation 404 1,816
Earnings on life insurance policies (2,967) (2,908)
Net change in:    
Trading account securities (8,320) (2,336)
Lease right-of-use assets 20,156 18,227
Accrued interest receivable and other assets (111,190) 69,262
Accrued interest payable and other liabilities 74,924 (594,338)
Net cash from operating activities 582,912 93,244
Investing Activities:    
Securities held-to-maturity - Purchases 0 (1,500)
Securities held to maturity: Maturities, calls and principal repayments 66,111 77,501
Securities available for sale:    
Purchases (17,045,631) (15,386,824)
Sales 27,916 41,207
Maturities, calls and principal repayments 14,976,788 13,903,659
Proceeds from sale of loans 9,373 14,119
Net change in loans (1,777,853) (712,382)
Benefits received on life insurance policies 2,326 1,777
Proceeds from sales of premises and equipment 8,856 44
Purchases of premises and equipment (142,676) (104,136)
Proceeds from sales of foreclosed assets 535 15,135
Net cash from investing activities (3,874,255) (2,151,400)
Financing Activities:    
Net change in deposits 1,304,507 (205,596)
Net change in short-term borrowings 592,258 230,608
Proceeds from stock option exercises 0 7,881
Purchase of treasury stock (178,349) (72,461)
Cash dividends paid on preferred stock (5,006) (5,006)
Cash dividends paid on common stock (193,739) (191,292)
Net cash from financing activities 1,519,671 (235,866)
Net change in cash and cash equivalents (1,771,672) (2,294,022)
Cash and cash equivalents at beginning of period 8,874,055 10,234,258
Cash and cash equivalents at end of period $ 7,102,383 $ 7,940,236